National Research Corp NRC
We take great care to ensure that the data presented and summarized in this overview for NATIONAL RESEARCH CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NRC
View all-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA3.06MShares$57.4 Million0.16% of portfolio
-
Black Rock Inc. New York, NY1.08MShares$20.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA986KShares$18.5 Million0.0% of portfolio
-
Atlanta Capital Management CO L L C Atlanta, GA959KShares$18 Million0.17% of portfolio
-
Morgan Stanley New York, NY919KShares$17.2 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX591KShares$11.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA421KShares$7.89 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny380KShares$7.12 Million0.01% of portfolio
-
State Street Corp Boston, MA363KShares$6.81 Million0.0% of portfolio
-
Qv Investors Inc.339KShares$6.36 Million0.68% of portfolio
Latest Institutional Activity in NRC
Top Purchases
Top Sells
About NRC
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Insider Transactions at NRC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 27
2024
|
John N Nunnelly |
SELL
Payment of exercise price or tax liability
|
Direct |
3,487
-9.65%
|
$135,993
$39.7 P/Share
|
Mar 27
2024
|
John N Nunnelly |
BUY
Exercise of conversion of derivative security
|
Direct |
9,259
+20.39%
|
$129,626
$14.95 P/Share
|
Mar 01
2024
|
Common Property Trust |
SELL
Open market or private sale
|
Indirect |
598,653
-13.44%
|
$23,946,120
$40.54 P/Share
|
Jan 05
2024
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
2,614
-0.07%
|
$104,560
$40.2 P/Share
|
Jan 04
2024
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
4,600
-0.12%
|
$188,600
$41.22 P/Share
|
Jan 03
2024
|
Common Property Trust |
SELL
Open market or private sale
|
Indirect |
364,625
-7.57%
|
$14,949,625
$41.53 P/Share
|
Jan 03
2024
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
120,139
-3.03%
|
$4,925,699
$41.77 P/Share
|
Jan 02
2024
|
Michael D. Hays CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,909
-65.74%
|
$74,451
$39.56 P/Share
|
Jan 02
2024
|
Michael D. Hays CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,904
+50.0%
|
$52,272
$18.8 P/Share
|
Jan 02
2024
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
201,100
-2.43%
|
$8,044,000
$40.7 P/Share
|
Dec 14
2023
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
600
-0.01%
|
$24,600
$41.59 P/Share
|
Dec 13
2023
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
3,779
-0.09%
|
$154,939
$41.55 P/Share
|
Dec 12
2023
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
21,884
-0.52%
|
$897,244
$41.55 P/Share
|
Dec 11
2023
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
37,638
-0.89%
|
$1,543,158
$41.55 P/Share
|
Dec 08
2023
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
12,328
-0.29%
|
$505,448
$41.55 P/Share
|
Dec 07
2023
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
4,738
-0.11%
|
$194,258
$41.56 P/Share
|
Dec 06
2023
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
952
-0.02%
|
$39,032
$41.6 P/Share
|
Dec 05
2023
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
1,498
-0.04%
|
$61,418
$41.6 P/Share
|
Dec 04
2023
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
100
-0.0%
|
$4,100
$41.6 P/Share
|
Nov 22
2023
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect |
627
-0.01%
|
$26,334
$42.08 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 12.2K shares |
---|
Open market or private sale | 1.38M shares |
---|---|
Payment of exercise price or tax liability | 5.4K shares |